Lilly Breast Cancer Treatment Moves Forward

Posted: Updated:
INDIANAPOLIS -

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says the U.S. Food and Drug Administration has accepted the New Drug Application for a potential breast cancer treatment. The application for abemaciclib also received a Priority Review designation, which aims to expedite the approval process by regulators.

Lilly says the NDA includes submission of the potential treatment of advanced breast cancer both on its own and in combination with another drug known as fulvestrant. With the Priority Review designation, the FDA could give is approval or rejection of the drug within eight months instead of the standard 12.

"We are pleased that the FDA has granted abemaciclib Priority Review, both as a potential monotherapy and combination therapy [with fulvestrant] for patients with advanced breast cancer," said Levi Garraway, senior vice president of global development and medical affairs with Lilly Oncology. "Breast cancer is a complex disease, and the need still exists for new treatment options as patients face a significant disease burden. We look forward to working with the FDA and bringing this important potential treatment option to patients as soon as possible."

Lilly says it expects the FDA to make a ruling on the treatment in first quarter 2018. The company says it also intends to submit the treatment to European regulators in third quarter 2017 and to Japanese regulators before the end of this year.

Last week, Lilly announced it had received approval from Japanese regulators for its once-daily treatment of rheumatoid arthritis.

  • Perspectives

    • The Evolution of Business: From Bottom Line to Value Creation And Impact

      In today's world, consumers want to know how corporations, as a whole, are taking a stand. In fact, customers are 43 percent more likely to purchase a product from a company they know is committed to social value. It's not just consumers pushing this trend. Financial service industry leaders, like KeyBank's Beth Mooney and BlackRock's Larry Fink, are challenging business owners and the C-Suite to rethink their economic impact, environmental footprint and social conscience.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • St. Vincent Announces Layoffs

      St. Vincent Health says it has laid off 85 employees throughout the state. In a statement to Inside INdiana Business, St. Vincent cites a rapidly-evolving healthcare environment as a reason for the workforce reduction. 

    • Indy Firm Taps Appirio Exec as CEO

      An Indianapolis-based design and innovation consulting firm has named a new chief executive officer. Studio Science says Steve Pruden, who most recently served as senior vice president of human resources with Indy tech company Appirio, will lead the company.

    • (Rendering provided by the city of Fishers.)

      New Office Building Planned in Fishers

      An $8.5 million office building is planned for the Fishers Certified Tech Park in Hamilton County. Plans call for a multi-story facility with 31,000 square-feet of space. Carmel-based The Hageman Group is partnering with the city on the project. Current properties in the Tech Park include Launch Fishers and the Indiana IoT Lab. President Shane Hageman says...

    • Old National Bringing on KleinBank

      Evansville-based Old National Bancorp (Nasdaq: ONB) has agreed to acquire a Minnesota bank. The all-stock transaction for Klein Financial Inc. is currently valued at nearly $434 million. The deal, which has received the approval from the Old National and Klein boards of directors, is expected to close in the fourth quarter. Old National says the acquisition will boost its asset total to approximately $20 billion. KleinBank's total assets come in at $2 billion. It has...

    • Herff Jones Owner to be Acquired

      The parent of Indianapolis-based Herff Jones will soon be under new ownership. Texas-based Varsity Brands has entered into an agreement to be acquired by Bain Capital Private Equity in Boston. Financial terms of the deal were not disclosed, however CNBC reports it is valued at $2.5 billion.